These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6834048)

  • 21. Origin of GABA-ergic strio-nigral neurons as studied by kainate-induced lesions.
    Porceddu ML; Morelli M; Del Fiacco M; Di Chiara G
    Pharmacol Res Commun; 1980 Jul; 12(7):695-8. PubMed ID: 7403239
    [No Abstract]   [Full Text] [Related]  

  • 22. The metabolism of GABA and other amino acids in rat substantia nigra slices following lesions of the striato-nigral pathway.
    Minchin MC; Fonnum F
    J Neurochem; 1979 Jan; 32(1):203-9. PubMed ID: 759573
    [No Abstract]   [Full Text] [Related]  

  • 23. gamma-Aminobutyric acid infusion in substantia nigra pars reticulata in rats inhibits ascorbate release in ipsilateral striatum.
    Christensen JC; Wang Z; Rebec GV
    Neurosci Lett; 2000 Feb; 280(3):191-4. PubMed ID: 10675793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Striato-nigral denervation increases type II benzodiazepine receptors in the substantia nigra of the rat.
    Corda MG; Concas A; Porceddu ML; Sanna E; Biggio G
    Neuropharmacology; 1986 Jan; 25(1):59-62. PubMed ID: 3005905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the unilateral striatal lesion on neurotransmitter markers in the contralateral striatum and both substantia nigrae of the rat.
    Masuo Y; Kanazawa I
    Neuroscience; 1988 Dec; 27(3):827-36. PubMed ID: 2908058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin-converting enzyme in substantia nigra: reduction of activity in Huntington's disease and after intrastriatal kainic acid in rats.
    Arregui A; Emson PC; Spokes EG
    Eur J Pharmacol; 1978 Nov; 52(1):121-4. PubMed ID: 214307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circling behavior following unilateral kainic acid injections into rat striatum.
    Taylor RJ; Reavill C; Jenner P; Marsden CD
    Eur J Pharmacol; 1981 Dec; 76(2-3):211-22. PubMed ID: 7333356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. gamma-Aminobutyric acid function in the rat striatum is under the double influence of nigrostriatal dopaminergic and thalamostriatal inputs: two modes of regulation?
    Samuel D; Kumar U; Nieoullon A
    J Neurochem; 1988 Dec; 51(6):1704-10. PubMed ID: 3141584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of girisopam (a 2,3-benzodiazepine derivative) to the substantia nigra is prevented by lesioning of the striatonigral pathway.
    Palkovits M; Lovas G; Horváth E
    Neuroscience; 1998 Apr; 83(3):799-806. PubMed ID: 9483563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increases in striatal and hippocampal impedance and extracellular levels of amino acids by cardiac arrest in freely moving rats.
    Korf J; Klein HC; Venema K; Postema F
    J Neurochem; 1988 Apr; 50(4):1087-96. PubMed ID: 2894408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gamma-aminobutyric acid turnover in rat striatum: effects of glutamate and kainic acid.
    Giorgi O; Meek JL
    J Neurochem; 1984 Jan; 42(1):215-20. PubMed ID: 6139420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of a vitamin E-deficient diet on amino acid levels in the substantia nigra, striatum and hippocampus of rats.
    Steffen V; Vizuete ML; Machado A; Cano J
    Life Sci; 1994; 54(5):375-9. PubMed ID: 8289599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum.
    Zeevalk GD; Manzino L; Sonsalla PK
    Exp Neurol; 2000 Feb; 161(2):638-46. PubMed ID: 10686083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of kainic acid on the hippocampal content of putative transmitter amino acids.
    Schmid R; Hong JS; Meek J; Costa E
    Brain Res; 1980 Nov; 200(2):355-62. PubMed ID: 6158363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative histochemical measurement of GABA-transaminase: method for evaluation of intracerebral lesions produced by excitotoxic agents.
    Gale K; Sarvey C; Stork J; Childs JA; Yalisove BL; Dayhoff RE
    Brain Res; 1984 Jul; 307(1-2):255-62. PubMed ID: 6466995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The localization of receptor binding sites in the substantia nigra and striatum of the rat.
    Reisine TD; Nagy JI; Beaumont K; Fibiger HC; Yamamura HI
    Brain Res; 1979 Nov; 177(2):241-52. PubMed ID: 227532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of kainic acid and AMPA on the release of taurine and GABA from the rat substantia nigra in vivo.
    Bianchi L; Colivicchi MA; Frosini M; Palmi M; Della Corte L
    Adv Exp Med Biol; 2000; 483():293-6. PubMed ID: 11787610
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition by apomorphine of the potassium-evoked release of [3H]-gamma-aminobutyric acid from the rat substantia nigra in vitro.
    Arbilla S; Kamal LA; Langer SZ
    Br J Pharmacol; 1981 Oct; 74(2):389-97. PubMed ID: 7317688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and Raphe nuclei.
    Molina-Holgado E; Dewar KM; Grondin L; van Gelder NM; Reader TA
    J Neurosci Res; 1993 Jul; 35(4):409-18. PubMed ID: 8360949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anterior striatal projections to the globus pallidus, entopeduncular nucleus and substantia nigra in the rat: the GABA connection.
    Nagy JI; Carter DA; Fibiger HC
    Brain Res; 1978 Dec; 158(1):15-29. PubMed ID: 21348349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.